Abstract
AbstractDynamically adapting the allocation of COVID-19 vaccines to the evolving epidemiological situation could be key to reduce COVID-19 burden. Here we developed a data-driven mechanistic model of SARS-CoV-2 transmission to explore optimal vaccine prioritization strategies in China. We found that a time-varying vaccination program (i.e., allocating vaccines to different target groups as the epidemic evolves) can be highly beneficial as it is capable of simultaneously achieving different objectives (e.g., minimizing the number of deaths and of infections). Our findings suggest that boosting the vaccination capacity up to 2.5 million first doses per day (0.17% rollout speed) or higher could greatly reduce COVID-19 burden, should a new wave start to unfold in China with reproduction number ≤1.5. The highest priority categories are consistent under a broad range of assumptions. Finally, a high vaccination capacity in the early phase of the vaccination campaign is key to achieve large gains of strategic prioritizations.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference42 articles.
1. Burgess, R. A. et al. The COVID-19 vaccines rush: participatory community engagement matters more than ever. Lancet 397, 8–10 (2020).
2. Gallagher, M. E. et al. Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates. Nat. Med. 27, 4–5 (2020).
3. Coronavirus vaccines: expect delays Q1 global forecast 2021. https://img.lalr.co/cms/2021/01/28193636/report-q1-global-forecast-2021-1.pdf (2021).
4. Wouters, O. J. et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet 397, 1023–1034 (2021).
5. So, A. D. & Woo, J. W. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ 371, m4750 (2020).
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献